These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Ozempic is primarily used for managing ... helps manage type 2 diabetes and has shown to aid in weight loss. Clinical trials showed that Trulicity helped reduce A1C levels by 1.5% to 1.9% over ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

They are doing it not primarily for weight loss — the effect that has made Ozempic a Hollywood staple and a reliable awards-show punchline — but for the surprising and widely touted side ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

A KKF poll finds that, overall, 12% of Americans have used or are using a GLP-1 agonist like Trulicity, Ozempic or Mounjaro for weight loss or to manage Type 2 diabetes and associated complications.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...